欧美日本另类精品久久,国产伦精品一区二区三区免费,亚洲人成影院午夜网站,久久久精品人妻一区二区三区蜜桃
中文簡體
中文簡體
English
HOME
ABOUT US
Company Profile
Company Culture
Company Honor
R&D
Technology Platform
Pipelines
NEWS
Press Release
Awards
CAREERS
CONTACT US
中文簡體
中文簡體
English
Search
/uploads/image/img/banner-txt-en-03.svg
首頁
-
NEWS
-
Press Release
Press Release
Awards
Press Release
Awards
Beihai Biotech announced that its innovative cancer drug, BH009 (marketed as BEIZRAY), has received approval from the U.S. Food and Drug Administration (FDA)
2024-10-31
U.S. FDA Formally Accepts Beihai Biotech's New Drug Application for Innovative Oncology Drug BH009 (BEIZRAY?)
2024-01-04
Beihai Biotech Founder Dr. Sun Invited to Keynote 'Wisdom in China' Summit at Renmin University Business School
2023-12-26
Beihai Biotech Successfully Concludes Series C Funding, Expediting BH009 Commercialization and Advancing Clinical Trials for Innovative Drug Candidates
2023-12-19
Beihai Biotech Secures “Drug Manufacturing Certificate”
2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023
2023-06-12
貝海生物用于治療晚期三陰性乳腺癌的創(chuàng)新藥物BH009獲批開展II期臨床試驗(yàn)
2023-04-10
貝海生物BH009新藥項(xiàng)目在晚期頭頸部鱗癌和卵巢癌患者中的I期臨床試驗(yàn)完成首例患者給藥
2023-03-09
<<
1
2
3
4
>>
ABOUT US
R&D
NEWS
CAREERS
CONTACT US
Contact Information
Company address:Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel:0756-6349669
Human resources contact:hr@bayhibiotech.com
Business cooperation contact:hjiang@bayhibiotech.com
Wechat Official Account
Copyright ? 2023 Zhuhai Beihai Biotech Co., Ltd.
Copyright Registration No. :
Guangdong ICP for 17134092
Technical support :
Xiangxun Technology
南宁市
|
抚州市
|
阿城市
|
若羌县
|
泸州市
|
宜宾县
|
南部县
|
邵阳市
|
莱阳市
|
双流县
|
镇宁
|
邳州市
|
肃南
|
托克托县
|
博野县
|
梓潼县
|
于都县
|
安平县
|
宁强县
|
丽江市
|
武安市
|
东辽县
|
绥江县
|
凌源市
|
莱芜市
|
鹤岗市
|
六安市
|
白河县
|
资溪县
|
罗甸县
|
丁青县
|
旬邑县
|
永泰县
|
桂东县
|
温州市
|
蒙自县
|
涞水县
|
天台县
|
白银市
|
神木县
|
轮台县
|